These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

822 related items for PubMed ID: 11951057

  • 1. Serodiagnostic and immunoprophylactic potential of a 78kDa protein of Leishmania donovani of Indian origin.
    Mukherjee M, Bhattacharyya A, Duttagupta S.
    Med Sci Monit; 2002 Apr; 8(4):BR117-22. PubMed ID: 11951057
    [Abstract] [Full Text] [Related]

  • 2. Characterization of two proteins from Leishmania donovani and their use for vaccination against visceral leishmaniasis.
    Jaffe CL, Rachamim N, Sarfstein R.
    J Immunol; 1990 Jan 15; 144(2):699-706. PubMed ID: 2295807
    [Abstract] [Full Text] [Related]

  • 3. Isotype profiles of Leishmania donovani-infected BALB/c mice: preferential stimulation of IgG2a/b by liposome-associated promastigote antigens.
    Afrin F, Ali N.
    J Parasitol; 1998 Aug 15; 84(4):743-8. PubMed ID: 9714204
    [Abstract] [Full Text] [Related]

  • 4. Identification of amastigote-specific antigens of Leishmania donovani using kala-azar patient sera.
    Gupta N, Goyal N, Bhatia N, Kamboj KK, Rastogi AK.
    Indian J Exp Biol; 2001 Jul 15; 39(7):623-8. PubMed ID: 12019753
    [Abstract] [Full Text] [Related]

  • 5. Pure protein from Leishmania donovani protects mice against both cutaneous and visceral leishmaniasis.
    Rachamim N, Jaffe CL.
    J Immunol; 1993 Mar 15; 150(6):2322-31. PubMed ID: 8450215
    [Abstract] [Full Text] [Related]

  • 6. Vaccination with Leishmania soluble antigen and immunostimulatory oligodeoxynucleotides induces specific immunity and protection against Leishmania donovani infection.
    Tewary P, Pandya J, Mehta J, Sukumaran B, Madhubala R.
    FEMS Immunol Med Microbiol; 2004 Oct 01; 42(2):241-8. PubMed ID: 15364110
    [Abstract] [Full Text] [Related]

  • 7. Enhanced efficacy and immunogenicity of 78kDa antigen formulated in various adjuvants against murine visceral leishmaniasis.
    Nagill R, Kaur S.
    Vaccine; 2010 May 21; 28(23):4002-12. PubMed ID: 20093205
    [Abstract] [Full Text] [Related]

  • 8. Induction of partial protection against Leishmania donovani by promastigote antigens in negatively charged liposomes.
    Afrin F, Anam K, Ali N.
    J Parasitol; 2000 Aug 21; 86(4):730-5. PubMed ID: 10958448
    [Abstract] [Full Text] [Related]

  • 9. Non PC liposome entrapped promastigote antigens elicit parasite specific CD8+ and CD4+ T-cell immune response and protect hamsters against visceral leishmaniasis.
    Sharma SK, Dube A, Nadeem A, Khan S, Saleem I, Garg R, Mohammad O.
    Vaccine; 2006 Mar 10; 24(11):1800-10. PubMed ID: 16310900
    [Abstract] [Full Text] [Related]

  • 10. Leishmania donovani p36(LACK) DNA vaccine is highly immunogenic but not protective against experimental visceral leishmaniasis.
    Melby PC, Yang J, Zhao W, Perez LE, Cheng J.
    Infect Immun; 2001 Aug 10; 69(8):4719-25. PubMed ID: 11447143
    [Abstract] [Full Text] [Related]

  • 11. Comparison of liposome based antigen delivery systems for protection against Leishmania donovani.
    Bhowmick S, Mazumdar T, Sinha R, Ali N.
    J Control Release; 2010 Jan 25; 141(2):199-207. PubMed ID: 19818373
    [Abstract] [Full Text] [Related]

  • 12. A mixed Th1/Th2 response elicited by a liposomal formulation of Leishmania vaccine instructs Th1 responses and resistance to Leishmania donovani in susceptible BALB/c mice.
    Mazumdar T, Anam K, Ali N.
    Vaccine; 2004 Mar 12; 22(9-10):1162-71. PubMed ID: 15003644
    [Abstract] [Full Text] [Related]

  • 13. Cross-protection against Leishmania donovani but not L. Braziliensis caused by vaccination with L. Major soluble promastigote exogenous antigens in BALB/c mice.
    Tonui WK, Titus RG.
    Am J Trop Med Hyg; 2007 Mar 12; 76(3):579-84. PubMed ID: 17360887
    [Abstract] [Full Text] [Related]

  • 14. Immunoblot analysis of the antibody response to antigens of Leishmania donovani in Indian kala-azar.
    Salotra P, Raina A, Negi NS.
    Br J Biomed Sci; 1999 Mar 12; 56(4):263-7. PubMed ID: 10795370
    [Abstract] [Full Text] [Related]

  • 15. Acylated and deacylated saponins of Quillaja saponaria mixture as adjuvants for the FML-vaccine against visceral leishmaniasis.
    Oliveira-Freitas E, Casas CP, Borja-Cabrera GP, Santos FN, Nico D, Souza LO, Tinoco LW, da Silva BP, Palatnik M, Parente JP, Palatnik-de-Sousa CB.
    Vaccine; 2006 May 01; 24(18):3909-20. PubMed ID: 16556475
    [Abstract] [Full Text] [Related]

  • 16. Leishmania donovani recombinant iron superoxide dismutase B1 protein in the presence of TLR-based adjuvants induces partial protection of BALB/c mice against Leishmania major infection.
    Daifalla NS, Bayih AG, Gedamu L.
    Exp Parasitol; 2012 Jul 01; 131(3):317-24. PubMed ID: 22580023
    [Abstract] [Full Text] [Related]

  • 17. Induction of cellular and humoral responses by autoclaved and heat-killed antigen of Leishmania donovani in experimental visceral leishmaniasis.
    Nagill R, Mahajan R, Sharma M, Kaur S.
    Parasitol Int; 2009 Dec 01; 58(4):359-66. PubMed ID: 19638322
    [Abstract] [Full Text] [Related]

  • 18. Protection of mice against visceral leishmaniasis by immunization with promastigote antigen incorporated in liposomes.
    Ali N, Afrin F.
    J Parasitol; 1997 Feb 01; 83(1):70-5. PubMed ID: 9057699
    [Abstract] [Full Text] [Related]

  • 19. Vaccination with recombinant Leishmania donovani gamma-glutamylcysteine synthetase fusion protein protects against L. donovani infection.
    Henriquez FL, Campbell SA, Roberts CW, Mullen AB, Burchmore R, Carter KC.
    J Parasitol; 2010 Oct 01; 96(5):929-36. PubMed ID: 20950100
    [Abstract] [Full Text] [Related]

  • 20. Th1-stimulatory polyproteins of soluble Leishmania donovani promastigotes ranging from 89.9 to 97.1 kDa offers long-lasting protection against experimental visceral leishmaniasis.
    Kumari S, Samant M, Misra P, Khare P, Sisodia B, Shasany AK, Dube A.
    Vaccine; 2008 Oct 23; 26(45):5700-11. PubMed ID: 18762224
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 42.